Literature DB >> 19060902

The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.

Monika Pruenster1, Liesbeth Mudde, Paula Bombosi, Svetla Dimitrova, Marion Zsak, Jim Middleton, Ann Richmond, Gerard J Graham, Stephan Segerer, Robert J B Nibbs, Antal Rot.   

Abstract

The Duffy antigen receptor for chemokines (DARC) belongs to a family of 'silent' heptahelical chemokine receptors that do not couple to G proteins and fail to transmit measurable intracellular signals. DARC binds most inflammatory chemokines and is prominently expressed on venular endothelial cells, where its function has remained contentious. Here we show that DARC, like other silent receptors, internalized chemokines but did not effectively scavenge them. Instead, DARC mediated chemokine transcytosis, which led to apical retention of intact chemokines and more leukocyte migration across monolayers expressing DARC. Mice overexpressing DARC on blood vessel endothelium had enhanced chemokine-induced leukocyte extravasation and contact-hypersensitivity reactions. Thus, interactions of chemokines with DARC support their activity on apposing leukocytes in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060902      PMCID: PMC3205989          DOI: 10.1038/ni.1675

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  53 in total

Review 1.  Signaling at zero G: G-protein-independent functions for 7-TM receptors.

Authors:  J A Brzostowski; A R Kimmel
Journal:  Trends Biochem Sci       Date:  2001-05       Impact factor: 13.807

2.  Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.

Authors:  Anna M Fra; Massimo Locati; Karel Otero; Marina Sironi; Paola Signorelli; Maria L Massardi; Marco Gobbi; Annunciata Vecchi; Silvano Sozzani; Alberto Mantovani
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

3.  Fy phenotype and gender determine plasma levels of monocyte chemotactic protein.

Authors:  P Jilma-Stohlawetz; M Homoncik; C Drucker; C Marsik; A Rot; W R Mayr; B Seibold; B Jilma
Journal:  Transfusion       Date:  2001-03       Impact factor: 3.157

4.  Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration.

Authors:  Kent W Christopherson; James J Campbell; Jeffrey B Travers; Robert A Hromas
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030

5.  Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia.

Authors:  Janet S Lee; Charles W Frevert; David R Thorning; Stephan Segerer; Charles E Alpers; Jean-Pierre Cartron; Yves Colin; Venus A Wong; Thomas R Martin; Richard B Goodman
Journal:  J Histochem Cytochem       Date:  2003-02       Impact factor: 2.479

6.  Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress.

Authors:  Jianguo Du; Jing Luan; Hua Liu; Thomas O Daniel; Stephen Peiper; Theresa S Chen; Yingchun Yu; Linda W Horton; Lillian B Nanney; Robert M Strieter; Ann Richmond
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

7.  Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC).

Authors:  T C Dawson; A B Lentsch; Z Wang; J E Cowhig; A Rot; N Maeda; S C Peiper
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

8.  The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis.

Authors:  S Segerer; H Regele; M MacK; R Kain; J P Cartron; Y Colin; D Kerjaschki; D Schlöndorff
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

9.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

10.  The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white?

Authors:  Alex B Lentsch
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

View more
  131 in total

1.  A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils.

Authors:  Sara Massena; Gustaf Christoffersson; Elina Hjertström; Eyal Zcharia; Israel Vlodavsky; Nora Ausmees; Charlotte Rolny; Jin-Ping Li; Mia Phillipson
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

2.  Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Authors:  Ziv Shulman; Shmuel J Cohen; Ben Roediger; Vyacheslav Kalchenko; Rohit Jain; Valentin Grabovsky; Eugenia Klein; Vera Shinder; Liat Stoler-Barak; Sara W Feigelson; Tsipi Meshel; Susanna M Nurmi; Itamar Goldstein; Olivier Hartley; Carl G Gahmberg; Amos Etzioni; Wolfgang Weninger; Adit Ben-Baruch; Ronen Alon
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

3.  Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.

Authors:  Prem Raj B Joseph; Jose M Sarmiento; Anurag K Mishra; Sandhya T Das; Roberto P Garofalo; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2010-07-14       Impact factor: 5.157

Review 4.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 5.  Emerging mechanisms of neutrophil recruitment across endothelium.

Authors:  Marcie R Williams; Verónica Azcutia; Gail Newton; Pilar Alcaide; Francis W Luscinskas
Journal:  Trends Immunol       Date:  2011-08-11       Impact factor: 16.687

6.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

Review 7.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 8.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

9.  A chemokine self-presentation mechanism involving formation of endothelial surface microstructures.

Authors:  Catherine Whittall; Oksana Kehoe; Sophie King; Antal Rot; Angela Patterson; Jim Middleton
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

10.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.